Singapore markets closed

BioCryst Pharmaceuticals, Inc. (BCRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
7.15+0.11 (+1.56%)
At close: 04:00PM EDT
7.12 -0.03 (-0.42%)
After hours: 07:39PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts11111211
Avg. Estimate-0.17-0.14-0.61-0.36
Low estimate-0.32-0.19-0.76-0.82
High estimate-0.14-0.1-0.51-0.08
Year ago EPS-0.4-0.19-1.18-0.61
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts10101110
Avg. Estimate98.32M103.21M402.24M474.84M
Low estimate96.66M101.5M395M383M
High estimate101.09M105.81M408.07M512.18M
Year ago sales82.49M85.95M331.41M402.24M
Sales growth (year/est)19.20%20.10%21.40%18.00%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.23-0.23-0.24-0.21
Actual EPS-0.4-0.19-0.31-0.17
Difference-0.170.04-0.070.04
Surprise %-73.90%17.40%-29.20%19.00%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.17-0.14-0.61-0.36
7 days ago-0.17-0.14-0.6-0.33
30 days ago-0.17-0.14-0.6-0.33
60 days ago-0.17-0.14-0.6-0.34
90 days ago-0.16-0.13-0.62-0.34
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/A11
Up last 30 daysN/AN/A11
Down last 7 daysN/AN/AN/AN/A
Down last 30 days11N/AN/A
Growth estimatesBCRXIndustrySector(s)S&P 500
Current qtr.57.50%N/AN/AN/A
Next qtr.26.30%N/AN/AN/A
Current year48.30%N/AN/AN/A
Next year41.00%N/AN/AN/A
Next 5 years (per annum)44.80%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A